This is the trial that settled the tirzepatide-vs-semaglutide debate
This is a side effect to monitor as more Phase 3 data becomes available, though it does not appear to be a major tolerability concern based on the initial data
After the first two months of Zepbound, your healthcare provider may increase your dose again first to 7.5 mg weekly
Its written on the pharmacy label and looks like this: mg/mL. A common one is 10 mg/mL
Additionally, the peptide appears to interact with multiple growth factor receptors and signaling pathways involved in cellular migration, proliferation, and differentiation, all essential processes for tissue healing
Iron supplements, pregnancy-related changes, and some hormonal medicines can also affect stool